Literature DB >> 12657391

Comparison of carbon dioxide and iodinated contrast for cavography prior to inferior vena cava filter placement.

Robert B Holtzman1, Lawrence Lottenberg, Thomas Bass, Angeleke Saridakis, Vicki J Bennett, Eddy H Carrillo.   

Abstract

BACKGROUND: The use of iodinated contrast in the critically ill trauma patient has been associated with the development of acute renal failure. The low incidence of nephrotoxicity associated with carbon dioxide (CO(2)) makes it an ideal contrast agent for cavography. However, the use of CO(2) has been limited, because reportedly it underestimates the diameter of the inferior vena cava (IVC).
METHODS: During a 6-month period (January 2000 through June 2000), 25 adult trauma patients required IVC filter placement. Bedside cavagrams using CO(2) followed by iodinated contrast were employed to determine the diameter of the IVC and the anatomy of the renal veins.
RESULTS: Using CO(2) injection for cavography, we were able to determine the diameter of the IVC and the anatomy of the renal veins in all patients. Furthermore, when CO(2) cavography was compared with the results obtained with iodinated contrast, the difference in diameter of the IVC was within 1 mm.
CONCLUSIONS: Based on these data, it was determined that CO(2) cavagrams accurately reflect the diameter of the IVC and the anatomy of the renal veins. Additionally, CO(2) cavagrams can be safely performed in the intensive care unit during bedside placement of IVC filters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657391     DOI: 10.1016/s0002-9610(02)01410-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

1.  Cavographic vs. cross-sectional measurement of the inferior vena cava diameter before filter placement: are we routinely oversizing?

Authors:  Yu-Dong Xiao; Zi-Shu Zhang; Cong Ma
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

2.  Carbon dioxide contrast medium for endovascular treatment of ilio-femoral occlusive disease.

Authors:  Cynthia de Almeida Mendes; Alexandre de Arruda Martins; Marcelo Passos Teivelis; Sergio Kuzniec; Andrea Yasbek Monteiro Varella; Alexandre Fioranelli; Nelson Wolosker
Journal:  Clinics (Sao Paulo)       Date:  2015-10       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.